pharmaphorum November 29, 2019

Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines. Richard Staines looks at the progress already made thanks to this potentially revolutionary technology, and how it could change the fortunes of a beleaguered pharma industry.

Artificial Intelligence (AI) has become the latest buzz word in drug R&D, and many of the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Precision Medicine, Technology
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Alphabet shares jump 14% on earnings beat, first-ever dividend
Microsoft: Unlocking AI Benefits Will Require Cultural Changes for Enterprises
Zephyr AI Raises $111 Million in Series A Financing
Chatbot answers are all made up. This new tool helps you figure out which ones to trust.

Share This Article